ATE332392T1 - Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide - Google Patents
Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptideInfo
- Publication number
- ATE332392T1 ATE332392T1 AT94917976T AT94917976T ATE332392T1 AT E332392 T1 ATE332392 T1 AT E332392T1 AT 94917976 T AT94917976 T AT 94917976T AT 94917976 T AT94917976 T AT 94917976T AT E332392 T1 ATE332392 T1 AT E332392T1
- Authority
- AT
- Austria
- Prior art keywords
- biologically active
- active polypeptides
- producing recombinant
- polypeptides
- antigen
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 102100037791 Macrophage migration inhibitory factor Human genes 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 108010008429 immunoglobulin-binding factors Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6104193A | 1993-05-14 | 1993-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332392T1 true ATE332392T1 (de) | 2006-07-15 |
Family
ID=22033267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94917976T ATE332392T1 (de) | 1993-05-14 | 1994-05-13 | Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0702725B1 (de) |
| JP (1) | JP3578787B2 (de) |
| KR (1) | KR960702868A (de) |
| CN (1) | CN1126494A (de) |
| AT (1) | ATE332392T1 (de) |
| AU (1) | AU692450B2 (de) |
| CA (1) | CA2162865A1 (de) |
| DE (1) | DE69434782T2 (de) |
| FI (1) | FI955463A (de) |
| HU (1) | HU219807B (de) |
| NO (1) | NO954568L (de) |
| NZ (1) | NZ267254A (de) |
| WO (1) | WO1994026923A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5910427A (en) * | 1995-06-22 | 1999-06-08 | La Jolla Institute For Allergy And Immunology | Antigen non-specific glycosylation inhibiting factor derivatives |
| DE19847690A1 (de) * | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
| EP1234038A1 (de) * | 1999-11-19 | 2002-08-28 | Transkaryotic Therapies, Inc. | Nucleinsäurekonstrukt zur optimalen herstellung von produkten |
| DE19957904A1 (de) * | 1999-12-01 | 2001-06-07 | Merck Patent Gmbh | Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung |
| SG176303A1 (en) * | 2009-06-10 | 2012-01-30 | Stephen Sanig Res Inst Ltd | Methods of generating cells exhibiting phenotypic plasticity |
| EP2731970B1 (de) | 2011-07-15 | 2018-11-28 | MorphoSys AG | Antikörper mit kreuzreaktion auf makrophagenmigrations-inhibitorfaktor (mif) und d-dopachrom-tautomerase (d-dt) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988007577A1 (en) * | 1987-03-31 | 1988-10-06 | Schering Biotech Corporation | Glycosylation inhibiting factors |
| EP0591320A4 (de) * | 1991-06-03 | 1994-11-23 | Jolla Inst Allergy Immunolog | Hybridom von suppressor-t-zellen. |
| ATE474597T1 (de) * | 1993-05-17 | 2010-08-15 | Cytokine Pharmasciences Inc | Inhibition des migrations-inhibitions-faktors in der behandlung von krankheiten bei denen eine cytokin-vermittelte toxizität eine rolle spielt |
-
1993
- 1993-12-27 JP JP33371293A patent/JP3578787B2/ja not_active Expired - Fee Related
-
1994
- 1994-05-13 AT AT94917976T patent/ATE332392T1/de not_active IP Right Cessation
- 1994-05-13 DE DE69434782T patent/DE69434782T2/de not_active Expired - Fee Related
- 1994-05-13 EP EP94917976A patent/EP0702725B1/de not_active Expired - Lifetime
- 1994-05-13 NZ NZ267254A patent/NZ267254A/en not_active IP Right Cessation
- 1994-05-13 KR KR1019950704924A patent/KR960702868A/ko not_active Application Discontinuation
- 1994-05-13 CN CN94192673A patent/CN1126494A/zh active Pending
- 1994-05-13 AU AU69488/94A patent/AU692450B2/en not_active Ceased
- 1994-05-13 WO PCT/US1994/005354 patent/WO1994026923A1/en active IP Right Grant
- 1994-05-13 CA CA002162865A patent/CA2162865A1/en not_active Abandoned
- 1994-05-13 HU HU9503249A patent/HU219807B/hu not_active IP Right Cessation
-
1995
- 1995-11-13 FI FI955463A patent/FI955463A/fi unknown
- 1995-11-13 NO NO954568A patent/NO954568L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69434782T2 (de) | 2007-06-14 |
| NZ267254A (en) | 1997-11-24 |
| HU9503249D0 (en) | 1996-01-29 |
| CN1126494A (zh) | 1996-07-10 |
| AU6948894A (en) | 1994-12-12 |
| JPH0884596A (ja) | 1996-04-02 |
| HU219807B (hu) | 2001-08-28 |
| CA2162865A1 (en) | 1994-11-24 |
| FI955463A (fi) | 1996-01-12 |
| EP0702725A1 (de) | 1996-03-27 |
| FI955463A0 (fi) | 1995-11-13 |
| JP3578787B2 (ja) | 2004-10-20 |
| AU692450B2 (en) | 1998-06-11 |
| KR960702868A (ko) | 1996-05-23 |
| NO954568L (no) | 1996-01-11 |
| DE69434782D1 (de) | 2006-08-17 |
| EP0702725A4 (de) | 1998-09-30 |
| HUT73213A (en) | 1996-06-28 |
| NO954568D0 (no) | 1995-11-13 |
| WO1994026923A1 (en) | 1994-11-24 |
| EP0702725B1 (de) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69636831D1 (de) | Verfahren zur herstellung heteromultimerer polypeptide | |
| EP0962467A4 (de) | Antikörper gegen menschliches parathormon verwandten peptide | |
| AU1986588A (en) | Growth hormone receptor | |
| ATE136908T1 (de) | Peptide und antikörper, die die integrin- ligandbindung inhibieren | |
| KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
| ES8606494A1 (es) | Un metodo de producir un peptido o polipeptido sintetico. | |
| ATE309353T1 (de) | Verfahren zur herstellung von rekombinanten peptiden | |
| ATE332392T1 (de) | Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide | |
| EP0759470A3 (de) | Für einen Endoglycoceramidase-Aktivator kodierendes Gen | |
| CA2088068A1 (en) | Protein structure of the plant toxin gelonin | |
| ATE313632T1 (de) | Durch pflanzen hergestellte rekombinante preduodenale lipase und abgeleitete polypeptide, verfahren zur herstellung und ihre verwendung | |
| HUT64369A (en) | Collagen binding protein and method for producing it | |
| CA2187386A1 (en) | Gene encoding endo-.beta.-n-acetylglucosaminidase a | |
| HUP0003541A2 (hu) | Expressziós vektor polipeptidek javított hatékonyságú előállítására élesztőben | |
| AU3931599A (en) | Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses | |
| ATE103973T1 (de) | Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung. | |
| NZ304789A (en) | Genes encoding lymphocyte interferon regulatory factory (lsirf) polypeptides that are transcription factors and specific antibodies to them | |
| DE68911713D1 (de) | Monoklonale Antikörper, die atriales natriuretisches Polypeptide erkennen, ihre Herstellung und Verwendung. | |
| WO2004089973A3 (en) | Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production | |
| IL139951A0 (en) | Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses | |
| UA35624C2 (uk) | МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО | |
| DE59509921D1 (de) | Integrationsvektoren zur Herstellung von Genen, die rekombinante Antikörper codieren | |
| DE69312502T2 (de) | Veränderung von polypeptiden | |
| GB8820284D0 (en) | Method for producing recombinant dna proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |